| Time | Topics | Speaker/s |
|
14:30
-
14:35
|
In Vivo Evaluation of Efficacy of Systemic Administration of Oral Slow Release Diclofenac Sodium on Intravitreal Concentration
|
Mojtaba Abrishami, MD
|
|
14:37
-
14:42
|
Investigating the CFH Gene Polymorphisms as a Risk Factor for Age Related Macular Degeneration in Iranian Population
|
Mojgan Babanejad, PhD
|
|
14:44
-
14:49
|
Intravitreal Sulfur Hexafluoride Gas for Vitreomacular Traction
|
Alireza Dehghani, MD
|
|
14:51
-
14:56
|
Intravitreal TPA for Treatment of Vitreomacular Adhesion
|
Saeed Karimi, MD
|
|
14:58
-
15:03
|
Clinical Patterns of Uveitis in Isfahan
|
Farzan Kianersi, MD
|
|
15:05
-
15:10
|
A Prospective Randomized Trial of Azithromycin Versus Trimethoprim/Sulfamethoxazole in Treatment of Toxoplasmicretinochoroiditis
|
Mohammad karim Johari, MD
|
|
15:12
-
15:17
|
The Efficacy of Intravitreal Interferon Alpha-2b for the Treatment of Experimental Endotoxin-Induced Uveitis.
|
Mehrdad Afarid, MD
|
|
15:19
-
15:24
|
Generation of Functional Retinal Pigmented Epithelium in Vitro
|
Hamid Aboutaleb Kadkhodaeean, PhD
|
|
15:26
-
15:31
|
The Effect of Periocular Injection of Celecoxib and Propranolol on Ocular Level of Vascular Endothelial Growth Factor in a Diabetic Mouse Model
|
Mostafa Feghhi, MD
|
|
15:33
-
15:38
|
Pilot Study of Intravitreal Injection of Bevacizumab in Primary Vitrectomy for Non Complex Retinal Detachment.
|
Adib Tusi, MD
|
|
15:40
-
15:45
|
Assessment of Peripapillary Retinal Thickness in Acute Central Retinal Vein Occlusion to Differentiate Ischemic from Non-Ischemic Type
|
Mostafa Mafi, MD
|
|
15:47
-
15:52
|
Combined Endoscopic Cyclophotocoagulation and Pars Plana Vitrectomy for Management of Diabetic Neovascular Glaucoma
|
Feisal Rahat, MD
|
|
15:54
-
16:00
|
Compatibility of Near-Infrared Autofluorescence Changes with Leakage Zone in Fluorescence Angiography of Acute Central Serous Chorioretinopathy
|
Hamid Riazi esfahani, MD
|